Current filters:


Popular Filters

1201 to 1221 of 1221 results

European Fine Chemicals Group ratifies US FDA's proposed Generic Drug User Fees Act


The board of the European Fine Chemicals Group (EFCG) says that it has agreed to ratify the proposal…

FinancialGenericsNorth AmericaRegulation

Aurobindo sets up JV with Diod to make and market generic drugs in Russia


Indian drugmaker Aurobindo Pharma (ARBN: BO) and OJSC Diod, a Russian manufacturer of ecological health…

Aurobindo PharmaDiodEuropeFinancialGenericsMarkets & MarketingMergers & Acquisitions

Exec appointments at SkyePharma, Impax, Ariad and Regeneron


UK-based drug delivery specialist SkyePharma (LSE: SKP) has appointed Pierre Delavaud as executive vice…

Ariad PharmaceuticalsGenericsImpax LaboratoriesManagementPharmaceuticalRegeneronSkyepharma

Rising number of alliances to drive generics cancer drugs market, says RNCOS


Increasing collaborations pertaining to cancer generics drugs have intensified in the recent times, says…

GenericsMarkets & MarketingOncology

Hungarian medicine budget plans reviewed by BMI


A new report, titled Hungary Pharmaceuticals and Healthcare Report Q4 2011 from Business Monitor International…

EuropeGenericsHealthcareMarkets & MarketingPharmaceutical

MSF accuses Novartis of trying to weaken Indian patent law


Novartis (NOVN: VX ) goes before the Indian Supreme Court today in the latest attempt by the Swiss multinational…


Ranbaxy debuts first approved generic of Nexium in the UK


The UK subsidiary of India largest drugmaker Ranbaxy (RANB: BO) says that it has successfully launched…

AstraZenecaEuropeGastro-intestinalsGenericsMarkets & MarketingNexiumRanbaxy Laboratories

Acino links with Berlin Pharma to market range of products in Thailand


Thailand-based Berlin Pharmaceutical Industry and Acino Pharma AG (SIX: ACIN) have signed a long term…

Acino PharmaAsia-PacificBerlin PharmaceuticalGenericsLicensingMarkets & MarketingPharmaceutical

US FTC long-awaited final report finds brand-name firms use leverage of authorized generic entry to delay competition


The USA’s Federal Trade Commission this week issued its final report, titled Authorized Generic…

GenericsLegalNorth AmericaPharmaceuticalRegulation

Pfizer in generic Lipitor deals with Sanofi and Dr Reddy’s


Global drugs behemoth Pfizer (NYSE: PFE) has reached agreement with French drug major Sanofi (Euronext:…

atorvastatinCardio-vascularDr Reddy's LaboratoriesGenericsLegalLicensingLipitorPfizerSanofiZentiva

PCMA outlines $100 billion in Rx drug savings in USA


As the USA’s Joint Select Committee on Deficit Reduction examines options to reduce the deficit…

BiotechnologyGenericsHealthcareNorth AmericaPharmaceuticalPricingRegulation

DMV-Fonterra to acquire Brahmar Cellulose in India


Germany’s DMV-Fonterra Excipients, a developer, producer and marketer of excipients to the pharmaceutical…

Brahmar CelluloseDMV-Fonterra ExcipientsGenericsMergers & Acquisitions

Public Citizen petitions US FDA to amend generic drug labeling regulations in the wake of Mensing


The US Food and Drug Administration should revise its regulations to allow generic drug manufacturers…

GenericsNorth AmericaPharmaceuticalRegulation

BASF hikes prices for pharmaceutical excipients and active ingredients


Effective September 1, 2011, Germany-based BASF (BAS: XE), the world’s largest chemical company,…


US and European physicians wary of using biosimilars without clinical data backing


The majority of US and European physicians are wary of using a biosimilar for an indication for which…

BiotechnologyEuropeGenericsMarkets & MarketingNorth AmericaResearch

Medivir’s new subsid BioPhausia AB sells generics business to Bluefish


Huddinge, Sweden-based infectious disease research specialist Medivir (OMX: MVIR) says it recently-acquired…

BioPhausiaBluefish PharmaceuticalsGenericsMedivirMergers & Acquisitions

1201 to 1221 of 1221 results

Company Spotlight



Back to top